Table 1.
Baseline characteristics of all patients, ischemic and hemorrhagic strokes as well as healthy controls.
| All | Ischemic strokes | Hemorrhagic strokes | Healthy controls | |
|---|---|---|---|---|
| N | 20 | 11 | 7 | 2 |
| Age (years; mean ± SD) | 63.4 ± 15.6 | 71.8 ± 10.2 | 58.4 ± 12.6 | 34.5 ± 0.7 |
| Sex (female:male) | 6:14 | 3:8 | 3:4 | 0:2 |
| Median time from symptom onset (hours; IQR) | 5.5 (1.7–12.0) | 8.3 (1.7–12.0) | 4.6 (2.3–10.3) | na |
| NIHSS at admission (median; IQR) | 5.0 (1.0–19.0) | 4.0 (1.0–8.0) | 12.0 (5.0–17.0) | na |
| ASA pretreatment (n; %) | 12 (60%) | 7 (63.6%) | 4 (57.1%) | 1 (50%) |
| Clopidogrel pretreatment (n; %) | 1 (5%) | 1 (9.0%) | 0 (0%) | 0 (0%) |
| Arterial hypertension (n; %) | 15 (75%) | 10 (90.9%) | 5 (71.4%) | 0 (0%) |
| Diabetes (n; %) | 5 (25%) | 4 (36.3%) | 1 (14.3%) | 0 (0%) |
| Coronary heart disease (n; %) | 5 (25%) | 2 (18.2%) | 3 (42.9%) | 0 (0%) |
| mRS at discharge (median; IQR) | 2 (1.0–4.0) | 1 (0.5–2.5) | 5 (3.0–5.0) | na |
SD, standard deviation; NIHSS, National Institutes of Health Stroke Scale; ASA, acetylsalicylic acid; mRS, modified Rankin Scale; na, not applicable.